The filarial parasite Wuchereria bancrofti is the major cause of lymphatic filariasis in tropical and subtropical regions of the world with an estimated 100 million people infected and an additional 900 million at risk of infection. ' Current methods of diagnosis of infection include identi fication of microfilariae by blood filtration, serodiagnosis by detection of an antibody to filarial antigen, and detection of circulating filarial antigen in the blood of infected patients. ' Each method suffers from a number of limitations. Hemo filtration requires the collection of blood samples when mi crofilariae are present in the peripheral circulation (usually at night between 10:00 PM and 2:00 @r@i in regions where the infection is nocturnally periodic). This is not only problem atic in obtaining the cooperation of the local population in community-based control programs, but also occult infec tions (infection in the absence of microfilariae) are not de tected by this method. In addition, species identification is difficult in regions coendemic for W. bancrofti and Brugia
malayi.
Serodiagnosis, while sensitive, is relatively nonspe cific and may be positive in subjects with exposure to filarial antigen without infection, in subjects with previous filarial infection, and in subjects infected with other helminths.2 As says that detect circulating W. bancrofti antigen enable the diagnosis of nocturnally periodic infections in day blood and the diagnosis of occult @ However, these assays fail to detect infection in some microfilaremic subjects.4 To investigate the possible efficacy of a DNA-based di agnostic test for W. bancrofti infection, a polymerase chain reaction (PCR) assay based on highly repeated DNA was developed. Previous studies have demonstrated the effec tiveness of DNA probes derived from the B. malayi Hha I repeat,59 and a PCR assay based on this repeat'Â°for detec tion of single microfilaria in blood samples from infected individuals. Unlike B. malayi, which has > 30,000 copies of the tandemly arranged Hha I repeat per haploid genome,
w. bancrofti hasmanydispersed repeat DNA families, each
consisting of dozens to hundreds of copies. This paper de scribes the cloning, characterization, and diagnostic utility of the highest copy number repeat family found in W. ban crofti. This 195-basepair (bp) genus-specific repeat is termed the Ssp I repeat and exists in all geographic isolates of the genus Wuchereria.
This sequence provides the basis of a PCR-based strategy for the detection of W. bancrofti DNA in the blood of infected patients.
MATERIALS AND METHODS
Isolation of DNA from parasites and construction of a genomic library. Wuchereriabancroftivar.pacifica micro filariae were collected from the blood of an infected Poly nesian donor. All restriction endonucleases, ligases, and link ers used in these experiments were obtained from New En gland Biolabs (Beverly, MA) and used as described by the supplier. Cloning kits (XgtlO) kits and Gigapack II Gold packaging kits were obtained from Stratagene (La Jolla, CA) and used as described by the manufacturer. Genomic W, ban Subcloning the repeat DNA into the pCRII vector. Cloning kits (TA 2000) containing the plasrnid pCRH were obtained from Invitrogen (San Diego, CA). All of. the PCR reagents used in these experiments were obtained from Per kin-Elmer (Norwalk, CT). Positive plaques identified in the screening with total genomic DNA were amplified by PCR using a pair of primers flanking the cloning site of the XgtlO vector (#123 1 and #1232; New England Biolabs). The PCR assays were carried out using the following conditions: de naturation for 10 mm at 95Â°C; followed by 35 cycles of 1 mm at 94Â°C, 1 mm at 55Â°C,and 1.5 mm at 72Â°C;followed by extension for 10 mm at 72Â°C.The amplified PCR prod ucts were subcloned into the pCRII plasmid vector according to the manufacturer's protocol. The positive recombinant plasmid clones were identified using PCR. In this method, cells from white (recombinant) colonies were picked and amplified using the original XgtlO PCR primers. If the PCR product had the same size as the original lambda clone, it was chosen for DNA sequence analysis.
DNA sequence analysis of the repeat clones. Plasmid DNA was isolated from 17 pCRIIJW. bancrofti repeat clones using the Plasmid Midi Kit from Qiagen (Chatsworth, CA). All of the repeat clones were sequenced by thermal cycle sequencing using the VentR(exoâ€") Sequencing Kit from New England Biolabs. The sequencing reactions were con ducted using a thermal profile of 20 sec at 95Â°C, 20 sec at 50Â°C,and 20 sec at 72Â°Cfor 20 cycles. The sequence data were analyzed using the MacVector software package from Scientific Imaging Systems (New Haven, CT) and the se quence analysis package from Genetics Computer Group (Madison, WI). The most common repeat sequence selected in this screening was 195 bp in length and contained a single Ssp I restriction site.
Southern and dot-blot hybridizations. Wuchereria ban
crofti genomic DNA and plasmid DNA were labeled non radioactively using fluorescein-l 1-dUTP by random priming (Enhanced Chemiluminescence
[ECL] Random Priming La beling System; Amersham). The 17-mer internal oligonucle otide ( Figure 1 ) was 3'-end labeled also using fluorescein I 1-dUTP (ECL 3'-Oligolabeling System; Amersham). Southern hybridizations were performed using protocols pro vided in the ECL kits except that nitrocellulose membranes (Schleicher & Schuell, Keene, NH) were used instead of nylon membranes. The membranes were incubated in ECL prehybridization buffer for 2 hr at 50Â°Cwhen random prime labeled genomic or plasmid DNA was the probe, and at 37Â°C when the 3' end-labeled 17-mer oligonucleotide was the probe. The filters were hybridized overnight with fluores cein-labeled probes at 50Â°C or 37Â°C, again depending on which probe was used. The protocols used for membrane washes, blocking, antibody incubations, and signal detection were as described by the manufacturer (Amersham).
For dot-blot hybridization experiments, DNA was filtered onto nitrocellulose membranes (Schleicher & Schuell). The filters were denatured using 0.5 M NaOH for 2 mm, and then neutralized using 1.0 M Tris-HC1 (pH 7.5) for S mm, and 0.5 M Tris-HC1 (pH 7.5)11.5 M NaCl for S mm. The filters were prehybridized, hybridized, washed, and detected using the same probes and protocols given above for Southern blots.
Developing the Ssp I PCR system. Based on the se quence of the Ssp I repeat, a pair of primers (NV-1 and NV 2) were designed for PCR amplification of the Ssp I repeat. The sequences are as follows: NV-i: 5' CGTGATGGCAT CAAAGTAGCG 3' (21-mer); NV-2: 5' CCCTCACTTAC CATAAGACAAC 3' (22-mer). These primers hybridize close to the ends of the 195-bp repeat and yield a l88-bp PCR amplification product. The PCR conditions using these two primers were optimized by titration of the concentra tions of MgCl2, deoxynucleotide triphosphates, primers, and Taq I polymerase. These titrations were conducted near the limit of detection for this PCR system (about 1 pg of W. bancrofti genomic DNA). The PCRs were conducted using ABCDEFGH I I 40 cycles of 1 mm at 94Â°C, 1 mm at 55Â°C, and 1 mm at 72Â°C,followed by a 72Â°Cextension for 10 mm. Following PCR, 20% of each sample was run on a 2.5% agarose gel and stained with ethidium bromide. To verify the identity of the l88-bp PCR amplification product, Southern blots of these gels were routinely performed and hybridized with the l7-mer internal oligonucleotide probe ( Figure 1 ).
Detection of microfflariae in blood by the Ssp I PCR
assay. Different numbers of W. bancrofti microfilariae from French Polynesia or Egypt were added to 50 pA of human blood. The samples were processed using the following pro tocol: 1) digestion with 15 pA of proteinase K (20 mg/mi) at 65Â°C for 3 hr; 2) extraction once with phenol, once with phenol/chloroform, and once with chloroform; and 3) dial ysis against 0. 1X TE (1 mM Tris-HC1, pH 8.0, 0. 1 mM EDTA) at room temperature for 4 hr. Each PCR included 5.0 pA of the dialyzed samples as templates. Following PCR, 20% of each sample was run on a 2.5% agarose gel and stained with ethidium bromide.
Detection of parasite DNA In blood and serum by the
Ssp I PCR assay. Different amounts of W. bancrofti geno mic DNA were added to 50 pA of human blood or serum. The samples were processed using the method described above and S pA of the processed samples were used as tern plates for PCR. Following PCR, 20% of each sample was run on a 2.5% agarose gel and stained with ethidium bro mide.
Screening blood samples using the Ssp I PCR assay. Human blood samples of 100 pA were collected in vacutai ners containing EDTA. Additional EDTA was added to a final concentration of 0. 1 M and samples were stored at â€"20Â°C. Later, the blood samples were thawed and processed using the following protocol: 1) digestion with 15 pA pro teinase K (20 mg/ml) at 65Â°C for 3 hr; 2) extraction once each with phenol, phenol/chloroform, and chloroform; and 3) dialysis against 0. 1X TE at room temperature for 4 hr. cutainers between 8:00 @i and noon when microfilarial den sity is at its peak in that area (unpublished data). Microfi larial density was assessed by standard i-mi blood filtration through 3-p@mpore size Nuclepore filters (Nucleopore Corp., Pleasanton, CA).' An additional 0.1 ml of blood was col lected for the PCR assay and preserved in EDTA and frozen as described above. These samples were processed for PCR using the method described above for detecting microfilariae in blood. The samples were then tested with the Ssp PCR assay using the 40-cycle program described above. An ad ditional 23 samples were collected in Indonesia from mdi viduals shown to have circulating B. malayi microfilariae. These samples were collected, processed, and PCR-tested in exactly the same manner as the Cook Island samples. Nucleotide sequence accession number. The DNA se quence data reported in this paper were submitted to GenBank@ and received the accession number L20344.
RESULTS

Characterization
of the Ssp I repeat DNA. Seventeen repeat clones were selected from screening the W. bancrofti XgtlO genomic library using total W. bancrofti genomic DNA as the probe. All of these clones were PCR-amplified and subcloned into the pCRII plasmid vector and sequenced. Two of the clones (WbTl2 and WbT14) showed 98% se quence identity for a l95-bp region. The other 15 clones JK 188 FIGURE 2. Sensitivity of the 5sp I polymerase chain reaction (PCR) system demonstrated by staining with ethidium bromide. Different amounts of Wuchereria bancrofti genomic DNA (1 ng to 0.01 pg) were used as the PCR template to test the sensitivity of the Ssp I PCR system using the optimal conditions (lanes Bâ€"J). Lanes A and K, 100-basepair (bp) ladder (molecular weight marker showed no sequence similarity to WbT12 and WbT14. The regions flanking the 195-bp repeat fragment in WbT12 showed no sequence similarity to the regions flanking the repeat in WbT14, indicating that this repeat family is dis persed. The DNA sequence analysis of WbTl2 and WbT14 showed a single Ssp I restriction site in both copies of this repeat. Thus, the sequences were designated the Ssp I repeat family. Base composition analysis indicates that this Ssp I repeat is very AT-rich (77% AT) (Figure 1 ). When equal amounts of DNA from all 17 repeat clones were spotted on a nitrocellulose filter and hybridized with W. bancrofti total genomic DNA, WbT12 and WbT14 gave the strongest sig nals. Six of the seventeen clones that gave the best sensitiv ity were labeled as probes to hybridize to serially diluted W. bancrofti genomic DNA on six dot-blots. The two Ssp I re peat DNA clones (WbTl2 and WbTl4) gave the best sen sitivity and species-specificity. Thus, the copy number of the Ssp I repeat was estimated at 300 copies per haploid genome. Optimizing the Ssp I PCR assay. A pair of PCR primers matching the two ends of the repeat was designed from the Ssp I sequence (Figure 1) . The Ssp I PCR was found to give the maximum yield of product when 300 p@MdNTP, 0.2 @iM NV-1 primer, 0.2 p.M NV-2 primer, I .5 mM MgCl2, and 0.04 U/pA of Taq DNA polymerase were used in the reaction.
Testing the sensitivity of the Ssp I PCR system. When
Ssp I PCR assays were carried out using the optimal con ditions, as little as 100 fg of W. bancrofti genomic DNA could be detected by staining with ethidium bromide ( ) microfilariae in blood using the Ssp I polymerase chain reaction (PCR) system. Different numbers (0â€"100)of French Polynesian or Egyptian W. bancrofti microfilariae were added to 50 pi of human blood. The samples were processed and the Ssp I PCRs were conducted as described. All of the samples containing microfilariae were PCR-positive. The blood samples without microfilariae were PCR-negative. The intensity of the ethidium bromideâ€"stained bands increased as the number of microfilariae increased. Lanes M, 100-basepair (bp) ladder (molecular weight marker).
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2), and 50 fg of W. bancrofti genomic DNA could be de tected on a Southern blot when hybridized with a 17-mer internal oligonucleotide probe of the Ssp I repeat. The lo cation and sequence of this internal oligonucleotide probe is shown in Figure 1 . The Southern blot also proved that the amplified PCR products were in fact the Ssp I repeat.
Testing the specificity of the Ssp I PCR system. The Ssp I repeat family was successfully amplified from DNA or microfilariae from all of the geographic isolates of W. ban crofti that were tested (Egypt, India, Thailand, Indonesia, Sri Lanka, Brazil and the Cook Islands) (Figure 3 ). This repeat was also amplified from W. kaiimantani, the only other spe cies in the genus Wuchereria (Figure 3) . Wuchereria kaii mantani is found only in Presbytis cristatus monkeys on the island of Kalimantan (Borneo) in Indonesia. When the Ssp I PCR system was used to amplify 16â€"50ng of DNA from other organisms, including humans, Ac. polynesiensis, Di with the 17-mer internal oligonucleotide probe (Figure 1 ). These data indicate that the Ssp I repeat family is genus-specific and that the repeat is found in W. bancrofti isolates throughout the world.
Detection of microfilariae in blood using the Ssp I PCR
system. One of the goals in developing the Ssp I PCR sys tem was to reliably detect very low numbers of microfilariae in blood samples. A reconstruction experiment was con ducted by adding different numbers of French Polynesian or Egyptian W. bancrofti microfilariae to 50 pA of human blood. The samples were processed using proteinase K digestion, organic extraction, and dialysis. Five microliters (1/10 vol ume) of each of the dialyzed samples were used as a tern plate for Ssp I PCR. A very strong signal could be observed when only five microfilariae were added to 50 pA of blood (Figure 4 ). Since only 1/10 of the sample was used for PCR, these data indicate that the assay should detect about one microfilaria in 100 pA or more of blood. The increased in tensity of the ethidium bromideâ€"stained bands as the number of microfilariae increased suggests the possibility of devel oping a semi-quantitative PCR assay. When the PCR signals of the French Polynesian and Egyptian microfilariae added to blood are compared, the intensity of the signal is virtually the same. This indicates that the Ssp I repeat family exists in similar copy number in these two geographic isolates of w. bancrofti.
Detection of parasite DNA in blood and serum using the Ssp I PCR assay. Reconstruction experiments were car ried out to investigate the use of the Ssp I PCR system to detect parasite DNA in blood and serum samples. Different amounts of genomic W. bancrofti DNA were added to 50 p.1 of human blood or serum. These samples were processed using the method described above. When S pA (1/10 volume)
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Fiouan 5. Detection of genomic Wuchereria bancrofti DNA added to blood or serum using the Ssp I polymerase chain reaction (PCR) system. Different amounts (0â€"100 pg) of W. bancrofti genomic DNA were added to 50 pi of human blood or plasma. The samples were processed and the Ssp I PCRs were conducted as described. All of the blood and plasma samples containing W. bancrofti DNA were PCR positive; the blood and plasma samples without W. bancrofti DNA were PCR-negative. Lanes M, 100-basepair (bp) ladder (molecular weight marker). The l88-bp Ssp I PCR product is not visible in the 1 pg lanes in this photograph. The bands were visible in the original photograph, however.
,â€" 188 bpâ€"4 primer/ â€"+@@ dimer A total of 100 p.1of blood from each of 47 residents of the W. bancrofti-endemic island of Mauke, Cook Islands, was subjected to analysis using the Ssp I PCR system. A 188-basepair (bp) band was visible in all 10 subjects with microfilaria (ml) counts ranging from 1 to 1,029/ ml (lanes 2â€"1 1) . The PCR of a blood sample from one of the amicrofilaremic subjects from the endemic area has no band visible (lane 1). The negative results from the other 36 residents without microfilariae (all negative for circulating antigen4) are not shown. Lane 12, PCR positive control with 50 pg of W. bancrofti genomic DNA (gDNA); lane 13, PCR-negative control (no DNA added to 100 pi of blood); lanes MW, lOO-bp ladder.
of the dialyzed samples were used as a template for PCR, a band was observed when as little as 1.0 pg of W. bancrofti DNA was added to the blood or serum ( Figure 5 ).
Detection of microfilaremla in clinical specimens using
the Ssp I PCR assay. Blood samples were collected from 47 residents of the W. bancrofti-endemic island of Mauke, Cook Islands in the South Pacific. Microfilaria counts ranged from 0 to 1,029/mi of blood. For each resident, 100 p.1 of blood was processed and subjected to analysis using the Ssp I PCR system as described in the Materials and Methods. A 188-bp band was visualized on ethidium bromideâ€"stained agarose gels for all 10 subjects who had microfilarial counts of 1â€"1,029/mi ( Figure 6 ). All 37 individuals without micro filaremia (and who were also circulating antigenâ€"negative) were negative using the Ssp I PCR assay. These results were confirmed when the PCR products were subjected to Southern blot hybridization with the Ssp I l7-mer internal hybridization probe. It should be noted that the intensity of the PCR signal obtained from the individual with one mi crofilaria/ml of blood was comparable to the signal obtained from the individual with 1,029 microfilariae/ml of blood (Figure 6 ), suggesting that fewer PCR cycles will be nec essary to develop a semi-quantitative format for the Ssp I PCR assay. '2 To test the specificity of the assay further, blood samples were collected from 23 microfilaria-positive Indonesians in fected with B. maiayi (50â€"300 microfilariae/ml). All 23 of these samples were negative when tested with the Ssp I PCR assay although they were positive when tested by the Hha I B. maiayi PCR assay.'Â°D
ISCUSSION
The sensitivity and specificity of the Ssp I PCR system has demonstrated its potential use as a diagnostic tool. The species-specificity of this assay could prove advantageous in a variety of circumstances. In some endemic areas, mosquito vectors carry more than one species of filarial parasite. Ssp I PCR assay can be used to detect very low numbers of microfilariae in blood samples. Samples with as few as one microfilaria/ml of human blood were detected in repeated trials, even though only 0. 1 ml of blood was processed for each PCR assay. This result, coupled with our demonstration that as little as 1 pg of W. bancrofti DNA could be detected in 0.1 ml of blood, suggests the possibility of detecting W. bancrofti infection in situations where microfilaria cannot be found in the blood. Indeed, preliminary experiments indicate that the Ssp I PCR assay is positive in day blood samples in areas where infection is nocturnally periodic, although these samples are likely to have small numbers (less than one per 5â€"10ml) of microfilariae even in the daytime. It can also be positive in some individuals who are amicrofilaremic but positive for circulating filarial antigen. While further re search will be necessary to validate these observations, it is likely that this assay will prove to be a useful diagnostic tool that will complement the other available diagnostic methods.
While not yet validated in large-scale clinical trials, the potential applications of the Ssp I PCR assay in the field include: 1) quantitative assessment of parasite burdens in human blood and in infected mosquitoes; 2) the ability to detect DNA in the absence of circulating microfilariae;
3) the ability to detect DNA in day blood of patients with noc turnally periodic strains of W. bancrofti; and 4) the ability to specifically identify W. bancrofti parasites in human pa thology samples when the speciation has been difficult based on morphologic evidence alone. Thus, the identification, characterization, and PCR-based utilization of the Ssp I re peat DNA provides the potential to improve the specific di agnosis of active W. bancrofti infection.
